Mortality prediction in diabetic patients with myocardial infarction: Experiences from the DIGAMI study

Cardiovascular Research

Volumn 34, Issue 1, 1997, Pages 248-253

  Malmberg, Klas ^a   Rydén, Lars ^a   Hamsten, Anders ^a   Herlitz, Johan ^b   Waldenström, Anders ^c   Wedel, Hans ^d  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^d The Nordic School pf Public Health   (Sweden)

Author keywords

Beta blockers; Diabetes; Human; Insulin; Morbidity; Mortality; Myocardial infarction; Prediction

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; INSULIN;

ADULT; AGED; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLUCOSE INFUSION; GLUCOSE METABOLISM; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN INFUSION; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ADRENERGIC BETA-ANTAGONISTS; AGE FACTORS; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INSULIN; MALE; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PROGNOSIS; RISK FACTORS;

EID: 0030976651     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(96)00263-5     Document Type: Article

References (39)

1. Abbott R, Donahue R, Kannel W, Wilson P. The impact of diabetes on survival following myocardial infarction in men and women. J Am Med Assoc 1988;260:3456-3460.
2. Malmberg K, Rydén L. Myocardial infarction in patients with diabetes mellitus. Eur. Heart J. 1988;9:256-264.
3. Rytter L, Froelsen S, Beck-Nielsen H. Prevalence and mortality of acute myocardial infarction in patients with diabetes mellitus. Diabetes Care 1985;8:230-234.
4. Abbud Z, Shindler D, Wilson A, Kostis J. Effect of diabetes mellitus on short- and long-term mortality rates of patients with acute myocardial infarction: A statewide study. Am Heart J 1995;130:51-58.
5. Orlander PR, Goff DC, Morrissey M, et al. The relation of diabetes to the severity of acute myocardial infarction and post-myocardial infarction survival in Mexican-Americans and non-Hispanic whites. The Corpus Christi Heart Project. Diabetes 1994;43:897-902.
6. Savage M, Krolewski A, Kenien G, Lebeis M, Christlieb R, Lewis S. Acute myocardial infarction in diabetes mellitus and significance of congestive heart failure as a prognostic factor. Am J Cardiol 1988;62:665-669.
7. Herlitz J, Malmberg K, Karlsson B, Rydén L, Hjalmarson Å. Mortality and morbidity during a five year follow-up of diabetics with myocardial infarction. Acta Med Scand 1988;24:31-38.
8. Jacoby R, Nesto R. Acute myocardial infarction in the diabetic patient: Pathophysiology, clinical course and prognosis. J Am Coll Cardiol 1992;20:736-744.
9. Malmberg K, Eféndic S, Rydén L. Feasibility of insulin-glucose infusion in diabetic patients with acute myocardial infarction. Diabetes Care 1994;17:1007-1014.
10. Malmberg K, Rydén L, Eféndic S, et al. A randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction: Effects on one year mortality. J Am Coll Cardiol 1995;26:57-65.
11. Malmberg K, Rydén L, Hamsten A, Herlitz J, Waldenström A, Wedel H. Effects of insulin treatment on cause specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. Eur Heart J 1996;17:1337-1334.
12. Cox D. Regression models and life-tables. J R Stat Soc (B) 1972;34:187-220.
13. Bueno H, Vidán T, Almazán A, López-Sendón L, Delcán J. Influence of sex on the short-term outcome of elderly patients with a first acute myocardial infarction. Circulation 1995;92:1133-1140.
14. Kuusisto J, Mykkanen L, Pyorala K, Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 1994;43:960-967.
15. Uusitupa M, Niskanen L, Siitonen O, Voutilainen E, Pyörälä K. Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 1993;36:1175-1184.
16. Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995;18:258-268.
17. Andersson D, Svärdsudd K. Long-term glycemic control relates to mortality in type II diabetes. Diabetes Care 1995;18:1354-1543.
18. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
19. Abraira C, Colwell J, Nutall F, et al. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results from the feasibility trial. Diabetes Care 1995;18:1113-1123.
20. Malmberg K, Herlitz J, Hjalmarsson Å, Rydén L. Effects of metoprolol on mortality and late infarction in diabetics with suspected acute myocardial infarction. Retrospective data from two large scale studies. Eur Heart J 1989;10:423-428.
21. Gundersen T, Kjekshus J. Timolol treatment after myocardial infarction in diabetic patients. Diabetes Care 1983;6:285-290.
22. Kjekshus J, Gilpin E, Cali G, Blackey A, Henning H, Ross Jr J. Diabetic patients and beta-blockers after acute myocardial infarction. Eur Heart J 1990;11:43-50.
23. Opie L, Thomas M. Propranolol and experimental myocardial infarction: substrate effects. Postgrad Med J 1976;52 (suppl 4):124-132.
24. Solomon S, Heckemeyer C, Barker J, Duckworth W. Hormonal control of lipolysis in perfused adipocytes from diabetic rats. Endocrinology 1985;117:1350-1354.
25. Chiappe de Cingolani G. β-Adrenergic receptors and adenylate cyclase activity in diabetic rat fat cells. Diabetes 1986;35:1229-1232.
26. Morgan H, Cadenas E, Regen D, Park C. Regulation of glucose uptake in muscle. III. Rate-limiting step and effects of insulin and anoxia in heart muscle from diabetic rats. J Biol Chem 1961;236:262-268.
27. Opie L. Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction. Relation to myocardial ischemia and infarct size. Am J Cardiol 1975;36:938-953.
28. Liedtke A. Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart. Prog Cardiovasc Dis 1981;23:321-336.
29. Ewing D. Cardiac autonomic neuropathy. In: Jarret R, ed. Diabetes and Heart Disease. Amsterdam: Elsevier, 1984:99-132.
30. Kjekshus J. Comments - betablockers: Heart rate reduction a mechanism of benefit. Eur Heart J 1985;6(suppl A):29-30.
31. Hjalmarson Å, Elmfeldt D, Herlitz J, et al. Effect on mortality of metoprolol in acute myocardial infarction. Lancet 1981;2:823-827.
32. Beta-Blocker Heart Attack Research Group. A randomised trial of propranolol in patients with acute myocardial infarction. I. Mortality results. J Am Med Assoc 1982;247:1707-1713.
33. Åblad B, Bjurö T, Björkman J, Edström T, Olsson G. Role of central nervous beta adrenoceptors in the prevention of ventricular fibrillation through augmentation of cardiac vagal tone. J Am Cardiol 1991;17:165A.
34. Curb J, Rodrigues B, Burchfiel C, Abbott R, Yano K. Sudden death, impaired glucose tolerance, and diabetes in Japanese American men. Circulation 1995;91:2591-2595.
35. Granger C, Califf R, Young S, et al. Outcome of atients with diabetes mellitus and acute mycardial infarction treated with thrombolytic agents. J Am Coll Card 1993;21:920-925.
36. Oswald G, Smith C, Betteridge J, Yudkin J. Determinants and importance of stress hyperglycaemia in non-diabetic patients with acute myocardial infarction. Br Med J 1986;293:917-922.
37. Yudkin J, Oswald G. Determinants of hospital admissions and case fatality in diabetic patients with myocardial infarction. Diabetes Care 1988;11:351-358.
38. Bellodi G, Manicardi V, Malvasi V, et al. Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus. Am J Cardiol 1989;64:885-888.
39. O'Sullivan J, Conroy R, Robinson K, Hickey N, Mulcahy R. In-hospital prognosis of patients with fasting hyperglycemia after first myocardial infarction. Diabetes Care 1991;14:758-760.